CMS has issued the Medicare Part B average sales price (ASP) files for the first quarter of 2013. CMS notes that average drug prices in the market generally remain relatively stable, with prices for the top Part B drugs decreasing by 1.2% on average. CMS also states that due to certain “operational issues,” it continues to delay implementation of its average manufacturer price -based price substitution policy at this time.